Current development and challenges of tetravalent live-attenuated dengue vaccines

J Hou, W Ye, J Chen - Frontiers in Immunology, 2022 - frontiersin.org
Dengue is the most common arboviral disease caused by one of four distinct but closely
related dengue viruses (DENV) and places significant economic and public health burdens …

A perspective on current flavivirus vaccine development: a brief review

SK Dutta, T Langenburg - Viruses, 2023 - mdpi.com
The flavivirus genus contains several clinically important pathogens that account for
tremendous global suffering. Primarily transmitted by mosquitos or ticks, these viruses can …

A modified mRNA vaccine targeting immunodominant NS epitopes protects against dengue virus infection in HLA class I transgenic mice

C Roth, T Cantaert, C Colas, M Prot… - Frontiers in …, 2019 - frontiersin.org
Dengue virus (DENV) induces strong T and B cell responses upon infection. Hence, it is
difficult to determine the contribution of cell-mediated immunity alone in the long lasting …

Challenges in dengue vaccines development: pre-existing infections and cross-reactivity

AM Izmirly, SO Alturki, SO Alturki, J Connors… - Frontiers in …, 2020 - frontiersin.org
Dengue is one of the most frequently transmitted mosquito-borne diseases in the world,
which creates a significant public health concern globally, especially in tropical and …

Recent developments in recombinant protein–based dengue vaccines

NK Tripathi, A Shrivastava - Frontiers in immunology, 2018 - frontiersin.org
Recombinant proteins are gaining enormous importance these days due to their wide
application as biopharmaceutical products and proven safety record. Various recombinant …

Structure and function of capsid protein in flavivirus infection and its applications in the development of vaccines and therapeutics

X Zhang, Y Zhang, R Jia, M Wang, Z Yin, A Cheng - Veterinary research, 2021 - Springer
Flaviviruses are enveloped single positive-stranded RNA viruses. The capsid (C), a
structural protein of flavivirus, is dimeric and alpha-helical, with several special structural …

The nucleocapsid protein of SARS-CoV-2, combined with ODN-39M, is a potential component for an intranasal bivalent vaccine with broader functionality

Y Lobaina, R Chen, E Suzarte, P Ai, V Huerta… - Viruses, 2024 - mdpi.com
Despite the rapid development of vaccines against COVID-19, they have important
limitations, such as safety issues, the scope of their efficacy, and the induction of mucosal …

Flavivirus vaccines: virus-like particles and single-round infectious particles as promising alternatives

E Cuevas-Juárez, V Pando-Robles, LA Palomares - Vaccine, 2021 - Elsevier
The genus flavivirus of the Flaviridae family includes several human pathogens, like
dengue, Zika, Japanese encephalitis, and yellow fever virus. These viruses continue to be a …

[HTML][HTML] Dengue vaccine–induced CD8+ T cell immunity confers protection in the context of enhancing, interfering maternal antibodies

JH Lam, YL Chua, PX Lee, JMM Gómez, EE Ooi… - JCI insight, 2017 - ncbi.nlm.nih.gov
Declining levels of maternal antibodies were shown to sensitize infants born to dengue-
immune mothers to severe disease during primary infection, through the process of antibody …

Can complementary prime-boost immunization strategies be an alternative and promising vaccine approach against dengue virus?

I Valdés, L Lazo, L Hermida, G Guillén… - Frontiers in Immunology, 2019 - frontiersin.org
Dengue is one of the most important diseases transmitted by mosquitoes. Dengvaxia®, a
vaccine registered in several countries, cannot be administered to non-immune individuals …